(Q38333556)

2 September 2017

title

Morpholino antisense oligomer targeting human midkine: its application for cancer therapy (English)

1 reference

2 September 2017

Yoshifumi Takei

1

1 reference

2 September 2017

Kenji Kadomatsu

2

1 reference

2 September 2017

Kanako Yuasa

3

1 reference

2 September 2017

Waichi Sato

4

1 reference

2 September 2017

Takashi Muramatsu

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

International Journal of Cancer

2 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 September 2017

volume

114

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

490-497

1 reference

Morpholino antisense oligomers: design, preparation, and properties

2 September 2017

cites work

1 reference

Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis

21 January 2018

1 reference

Increased midkine gene expression in human gastrointestinal cancers.

21 January 2018

1 reference

Midkine induces the transformation of NIH3T3 cells

21 January 2018

1 reference

Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by Midkine

21 January 2018

1 reference

Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase

21 January 2018

1 reference

Morpholino antisense oligomers: the case for an RNase H-independent structural type

21 January 2018

1 reference

Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.20781

1 reference

2 September 2017

1 reference